Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multi-Center, Open-label, Pharmacokinetic Drug Interaction Study of AMG 334 and a Combined Oral Contraceptive in Healthy Female Subjects

Trial Profile

A Multi-Center, Open-label, Pharmacokinetic Drug Interaction Study of AMG 334 and a Combined Oral Contraceptive in Healthy Female Subjects

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 13 Apr 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Erenumab (Primary) ; Estradiol congener-compounds/progesterone congener compounds
  • Indications Migraine
  • Focus Pharmacokinetics
  • Sponsors Amgen
  • Most Recent Events

    • 08 Apr 2019 Results assessing drug-drug interactions between Erenumab and an ethinylestradiol/norgestimate COC in healthy women published in the CNS Drugs
    • 11 Jun 2017 Results (n=22) presented at the 59th Annual Scientific Meeting of the American Headache Society.
    • 08 Jun 2017 According to an Amgen media release, the company will present data from this study at the 59th Annual Scientific Meeting of the American Headache Society 2017.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top